Wednesday, Sept. 28, 2022: Cramer says buy this drugmaker, even after hitting all-time high

Jim Cramer and Jeff Marks break down why they do not see the Federal Reserve following the Bank of England's lead in intervening in the hot bond market. They also share a pharmaceutical name they like more than the rest, and explain why it is a buy right now.